Since anti-angiogenic strategies that directly target VEGF pathway have been well-described and many agents have been included in anti-angiogenesis trials [32], synthetic miR-573 and miR-578 mimics could be a possible promising novel strategy to inhibit blood vessels sprouting in BRCA-related breast tumors. This evidence concerns the gene VEGFA and breast neoplasm.